Urology

Latest Ask the Experts

Biomarker Assays for Prostate Cancer Management

Should biomarker assays be an integral part of prostate cancer patient care?

Urology News

Latest Urology News

Kidney Cancer Overweight-Related Cancers Common in the US

Overweight-Related Cancers Common in the US

40% of cancer diagnoses tied to extra weight; rate higher in older individuals, females.

Urology Surgeon Gender Linked With 30-Day Mortality

Surgeon Gender Linked With 30-Day Mortality

But surgeon sex is not associated with differences in readmissions or complications.

Kidney Cancer RCC Subtypes Affect Post-Surgery Cancer-Related Mortality Risk

RCC Subtypes Affect Post-Surgery Cancer-Related Mortality Risk

Patients with papillary versus clear cell renal cell carcinoma have a 24% decreased risk of dying from their cancer.

Prostate Cancer Genetic Variant Predicts Faster Time to Prostate Cancer Metastasis

Genetic Variant Predicts Faster Time to Prostate Cancer Metastasis

The variant HSD3B1 allele increases the likelihood of metastasis in men receiving androgen-deprivation therapy for biochemically recurrent disease after radiotherapy for localized PCa.

Prostate Cancer Men With PCa Most Likely to Die From Other Causes

Men With PCa Most Likely to Die From Other Causes

Non-metastatic prostate cancer patients are more likely to die from causes other than the disease.

Bladder Cancer COBRA Score Gauges Mortality Risk After Cystectomy

COBRA Score Gauges Mortality Risk After Cystectomy

Tool incorporates the relative contribution of tumor stage, lymph node involvement.

Prostate Cancer Prostate Cancer Hormone Therapy Ups Cardiac Risks

Prostate Cancer Hormone Therapy Ups Cardiac Risks

Exposure to androgen-deprivation therapy was associated with a nearly 2-fold increased risk of heart failure among men without pre-existing cardiovascular disease.

Urology Reported Penicillin Allergy Ups Surgical Site Infection Risk

Reported Penicillin Allergy Ups Surgical Site Infection Risk

Increased risk of SSI was mediated by patients' receipt of alternative perioperative antibiotic.

Overactive Bladder (OAB) Methylene Blue Improves Onabotulinum Toxin A Injection Technique

Methylene Blue Improves Onabotulinum Toxin A Injection Technique

Methylene blue aids observation of the procedure and assessment of drug distribution.

Urinary Tract Infections (UTI) Meat Often Contains Bacteria Linked to UTIs

Meat Often Contains Bacteria Linked to UTIs

Almost one-fourth of retail poultry contains E. coli strains associated with urinary tract infections

Prostate Cancer Robotic Prostatectomy Centers Rising in the UK

Robotic Prostatectomy Centers Rising in the UK

Radical prostatectomy centers that closed from '10 to '14 more likely in areas with strong competition.

Prostate Cancer Clinicians Embrace New Prostate Cancer Grading System

Clinicians Embrace New Prostate Cancer Grading System

Endorsed by the International Society of Urological Pathology in 2014, the 5-tier Gleason grade group system is used routinely today in pathology reports and physician counseling of patients with newly diagnosed prostate cancer.

Bladder Cancer Hypermutated ctDNA: A Marker of Checkpoint Inhibitor Response?

Hypermutated ctDNA: A Marker of Checkpoint Inhibitor Response?

Patients with high alteration number in variants of unknown significance had better outcomes.

Urology Optimal Post-Op Opioid Pain Rx Explored

Optimal Post-Op Opioid Pain Rx Explored

Optimal length for each procedure lies between observed median prescription length and early nadir.

Bladder Cancer Immune Checkpoint Inhibitors Linked With Endocrine Dysfunction

Immune Checkpoint Inhibitors Linked With Endocrine Dysfunction

Patients on combination therapy have increased risk of thyroid dysfunction and hypophysitis.

News Group Proposes Lower P-Value for Statistical Significance

Group Proposes Lower P-Value for Statistical Significance

In a controversial and divisive article, a group of researchers proposes to improve "statistical standards of evidence" by lowering the P value from P <.05 to P <.005 in the fields of biomedical and social sciences.

Prostate Cancer Brachytherapy + EBRT for High-Risk PCa Offers 'Excellent' Outcomes

Brachytherapy + EBRT for High-Risk PCa Offers 'Excellent' Outcomes

Biochemical failure and prostate cancer-specific mortality rates were 13.3% and 4.9% at 10 years, respectively.

Prostate Cancer Prostate Cancer Pathologic Stage Alone Independently Predicts BCRFS

Prostate Cancer Pathologic Stage Alone Independently Predicts BCRFS

Pathologic stages T3a and T3b versus T2a were associated with 8.45 and 7.1 times increased risk of biochemical recurrence on multivariable analysis.